UPDATE 1-Hyundai’s local car sales hit 10-month low

SEOUL, July 1 (Reuters) – South Korea’s Hyundai Motor Co posted a third successive monthly decline in domestic sales to a 10-month low on Thursday, hit by tough competition in the absence of new models, although the pace of decline moderated.

Hyundai (005380.KS), one of the top global performers during the financial crisis and sales slump that followed, said June domestic sales edged down 1.2 percent from May to 48,643 units, the lowest since August last year.

Overall sales, however, rose 4.6 percent to 312,388 vehicles, helped by strong performance in such markets as the United States, India and China. [ID:nSEU003077]

Hyundai is the sole Korean automaker to post falling local sales for three months in a row in the face of new model launches by affiliate Kia Motors (000270.KS) and aggressive marketing of imports by rivals such as Toyota Motor (7203.T).

Some analysts predicted Hyundai’s struggle in the local market would continue until it starts introducing new models from August.

Kia Motors, South Korea’s second-largest carmaker, posted record monthly sales of 178,391 vehicles, spurred by solid domestic sales growth for its new K5 sedan and Sportage R SUV models. [ID:nSEU003076]

Its first-half sales jumped 49 percent from a year ago to a record 990,261 units.

Ssangyong Motor (003620.KS), which is up for sale and has opened its books to bidders including Franco-Japanese alliance Renault-Nissan and India’s Mahindra & Mahindra (MAHM.BO), reported record monthly sales of 7,422 units. [ID:nTOE66001X]

Shares in Hyundai tumbled 5 percent on Thursday, hit by a report that its parent group may bid for a $2.1 billion stake in its former affiliate Hyundai Engineering & Construction (000270.KS), a deal from which analysts see few synergy benefits. [ID:nTOE66000B]

With weak domestic sales remaining a prime source of concern, eyes are now on Hyundai’s performance in the jittery U.S. market, which will be released later on Thursday.

U.S. auto sales for June are likely to slip from the pace of recent months, raising doubts about whether the industry’s recovery is faltering even before it delivers the second-half upturn automakers expected. [ID:nN30214950]

(Reporting by Miyoung Kim; Additional reporting by Suh Kyungmin and Seo Jiwon; Editing by Jonathan Hopfner)

Hyundai domestic sales slump in May

(Reuters) – South Korea’s largest carmaker, Hyundai Motor Co Ltd (005380.KS), posted a steeper-than-expected 23 percent decline in domestic sales in May as competition stepped up, pulling its shares to a three-week closing low.

Hyundai, one of the top global performers during the financial crisis and sales slump that followed, continued to post a rise in overseas sales in May. But it was the sole Korean automaker with falling local sales for two months in a row in the face of new model launches by affiliate Kia Motors Corp (000270.KS) and aggressive marketing of imports by rivals such as Toyota Motor Co (7203.T).

“A second consecutive fall in domestic sales is quite worrying, although year-ago comparison numbers were relatively high,” said Lee Sang-hyun, an analyst at NH Investment & Securities.

“It was hit by aggressive marketing by rivals and new model launches by Kia and Renault-Samsung and those factors may continue to depress domestic sales, although Hyundai plans to introduce new models later this year.”

Hyundai lowered the price of its Genesis sedan from Tuesday by dropping some of its more expensive options as foreign cars, including Daimler’s (DAIGn.DE) Mercedes-Benz, gain ground at more affordable prices.

It could face a further battle after Ssangyong Motor (003620.KS), the country’s smallest carmaker, drew seven preliminary bidders, including France’s Renault SA (RENA.PA) and India’s top utility vehicle maker Mahindra & Mahindra (MAHM.BO) last week in a deal worth up to $500 million.

The participation of high-profile international firms in the auction was seen as a potential threat to the dominance enjoyed by Hyundai and Kia, which controls 80 percent of South Korea’s auto market.

Hyundai shares extended losses after the monthly results before closing down 5.4 percent, its lowest close since May 11. It was the sixth-worst performer on the KOSPI for the day.

The stock spiked to a record high in mid-May, up as much as 21 percent in 2009 and outperforming a 1 percent rise in the wider market on expectations of strong sales. The stock is now almost 10 percent off its peak.

Overall May sales climbed 19 percent to 298,036 vehicles from a year earlier, but sales at home fell 22.7 percent to 49,228 units, missing Nomura’s forecast of a 15 percent drop. Sales of its YF Sonata sedan, which was launched late last year, almost halved in South Korea.

“May of last year saw a sharp increase in sales with the introduction of the clunker subsidies and ahead of the end of consumption tax cuts,” Hyundai said in a statement.

“That made the pace of sales fall bigger, and deepening competition for major models weighed on May sales.”

In contrast, overseas sales jumped by a third to 248,808 cars last month, above market expectations, helped by a series of upgraded models. However that still represented a month-on-month decline of 7.1 percent.

Hyundai’s average incentive levels are much lower than the industry average in the U.S. market and concerns about a slowdown in world economic recovery on European debt woes may cloud Hyundai’s second-half outlook.

But analysts say the weaker won following tensions with North Korea should prop up Hyundai’s overseas sales.

The full launch of Kia’s U.S. plant in Georgia, which produces Sorento R SUVs, bumped up its overseas sales by 46.1 percent.

Ssangyong Motor more than doubled May sales from a year earlier, selling a total of 7,028 vehicles at home and abroad.

($1=1194.5 Won)

(Additional reporting by Miyoung Kim and Cheon Jong-woo; Editing by Nick Macfie and Lincoln Feast)

China 3G TD-SCDMA Handset Shipments to Grow 600 Percent in 2010

BOSTON–(Business Wire)–
According to the latest research from Strategy Analytics, China`s 3G TD-SCDMA
handset shipments will grow 600 percent during 2010. With the backing of the
world`s largest mobile operator, China Mobile, TD-SCDMA will be one of the
fastest growing mobile technologies in the world, making China an important 3G
market.

Tom Kang, Director at Strategy Analytics, said, “We forecast TD-SCDMA handset
shipments to grow an impressive 600 percent annually in China during 2010.
Aggressive marketing and subsidizing of new phones and keener pricing of
services by China Mobile will make TD-SCDMA one of the world`s fastest growing
mobile technologies.”

Neil Mawston, Director at Strategy Analytics, added, “The surging volumes of
TD-SCDMA handsets will make China an important 3G market that no major brand can
afford to ignore. Companies that we expect to benefit from the growth of
TD-SCDMA will include Nokia, Samsung, ZTE, Huawei, MediaTek, ST-Ericsson and
Spreadtrum. If Apple eventually chooses to launch a TD-SCDMA version of its
iPhone, then we believe this would ignite the market and provide considerable
upside for Apple in China.”

The full report, Global Handset Sales Forecast by Country: 2002 to 2015, is
published by the Strategy Analytics Wireless Device Strategies (WDS) service,
details of which can be found here.

About Strategy Analytics:

Strategy Analytics is a global, independent research and consulting firm. The
company is headquartered in Boston, USA, with offices in the UK, France,
Germany, Japan, South Korea and China. Visit www.strategyanalytics.com for more
information.

Strategy Analytics
Asia Contact:
Thomas Kang, +82 10 2874 8133
TKang@strategyanalytics.com
or
Europe Contact:
Neil Mawston, +44 1908 423 628
NMawston@strategyanalytics.com
or
USA Contact:
Alex Spektor, +1 617-614-0726
ASpektor@strategyanalytics.com

Copyright Business Wire 2010

BlackBerry Curve outsells the iPhone 3G

BlackBerry Curve outsells the iPhone 3GThe smartphone sales race may be closer than expected.

Research In Motion’s BlackBerry Curve overtook Apple’s iPhone to become the top-selling consumer smartphone in the United States during the first quarter of 2009, according to research published by NPD Group on Monday.

NPD’s monthly “Smartphone Market Update” report, based on online surveys of consumers, now ranks the best-selling consumer smartphones in the U.S. as follows:

1. RIM BlackBerry Curve (all 83XX models)
2. Apple iPhone 3G (all models)
3. RIM BlackBerry Storm
4. RIM BlackBerry Pearl (all models, except flip)
5. T-Mobile G1

NPD attributed the recent BlackBerry sales surge to an aggressive “buy one, get one free” promotion for the phone by carrier Verizon Wireless. It helped boost RIM’s share of the consumer smartphone market 15 percent to capture nearly 50 percent of the market in the first quarter, NPD said in a statement.

“Verizon Wireless’ aggressive marketing of the BlackBerry Storm, and its buy-one-get-one BlackBerry promotion to its large customer base, contributed to RIM capturing three of the top five positions (in U.S. smartphone sales),” Ross Rubin, director of industry analysis at NPD, said in a statement. “The more familiar, and less expensive, Curve benefited from these giveaways and was able to leapfrog the iPhone, due to its broader availability on the four major U.S. national carriers.”

Source By Cnet.com

DGCA figures show 15% year-on-year drop in number of air passengers in March

As per the latest air travel-related data, coming from the Directorate General of Civil Aviation (DGCA), there has been a 15 percent fall in the year-on-year figures concerning total number of passengers carried by the nine Indian airlines in March – the number coming down from the previous year’s 37.11 lakh to the recent 31.60 lakh.

The government data shows that the plunge in the number of passengers taking the air route has been continuing over the past nearly 11 months; and the key reasons for the decline is the decreased number of foreign tourist arrivals.

According to Kapil Kaul – India head of Centre for Asia Pacific Aviation – while the low demand during the mid-January to mid-April period is a usual occurrence, the number of passengers dropped in March largely due to higher airfares over the last few months. Saying that rising fares naturally lead to a fall in traffic, Kaul added that, in the coming months, aggressive marketing strategies will likely kbe adopted by full-service airlines, with the aim of enticing passengers.

The most prominent airlines to be worst-hit by the plunging number of air passengers in March included Jet Airways, with nearly 2.68 lakh fewer passengers than last year; and Kingfisher, with almost 2.34 lakh fewer passengers than flown by Kingfisher and Air Deccan the year before.

Indian link boosts S African Cipla Medpro profits

Johannesburg, April 3 (IANS) Exclusive access to a wide range of products from Cipla India helped boost revenues of pharmaceutical company Cipla Medpro South Africa by nearly 40 percent, the company reported.

With its revenues growing at 38.8 percent, Cipla Medpro again continued to grow faster than the total private market, but the company posted a loss of 15.6 million rands before interest and tax because of the huge costs of making its plant at Durban compliant with the Pharmaceutical Inspection Convention, it said on the Johannesburg Securities Exchange website.

Currently operating at 20 percent capacity, this highly sophisticated plant has an annual output capability of 3.5 billion tablets (with reserve) and may still take some time to see significant revenues being generated.

Growth was recorded across numerous categories, such as neuropsychiatry, asthma, cardiovascular, over the counter (OTC) and animal health.

This growth was attributed to product launches, exclusive access to Indian pharmaceutical giant Cipla India’s strong pipeline of products and dossiers, a strong and rapidly expanding OTC product portfolio, listings in mass market retailers, a large sales force and a continued aggressive marketing strategy.

Twenty five new products were launched during the year across all categories – skincare, colds and flu, and nutritional supplements, and further launches are scheduled for 2009.

Cipla said that its antidepressant, Lexamil, and its cardiovascular product, Cipla Perindopril, were each gaining market share of almost 40 percent in their markets, reflecting a trend of increased demand for these two stress-related drug types in the current global financial meltdown.

Cipla is also one of the leading generic anti-retroviral producers, having won a government contract last year. This will see the entry of supplies from the local plant, as well as from the Mumbai-based plant, Cipla India.

The pipeline from Cipla India remains strong, with the benefit of favourable prices and payment terms. Cipla Medpro currently has 155 dossiers awaiting registration, another 37 about to be submitted and a further 46 dossiers ordered from Cipla India for delivery over the next 12 months.

Cipla Vet, the companion animal veterinary products business, has recently launched the first generic of the world’s biggest selling tick and flea product, with the company projecting significant market share gains in this category during 2009.

After in-depth industry research and analysis, the new agricultural chemicals division, Cipla Agricare launched recently with a comprehensive range of 21 internationally SGA-certified pesticides. With another 12 products expected soon from Cipla India for local trials and registration and a further six ready for registration, it is envisaged that the targeted market share and revenues are attainable within approximately four seasons.